Product Information
LABETALOL HCL 100 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0850 per EA under NDC 72888012001. Its NADAC has been published 237 times since Feb 9, 2022.
FDA first approved this application on Aug 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888012001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211953FDA Approved
8/18/2021
TE Code
AB
On Market Since
8/18/2021
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 100 MG TABLET has been published 237 times since Feb 9, 2022, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.1287 (Apr 13, 2022) |
| All-time low | $0.0789 (Mar 18, 2026) |
| 52-week high | $0.0852 |
| 52-week low | $0.0789 |
| Median price | $0.1052 |
| Average price | $0.1015 |
| Largest weekly change | +34.4% (Jun 19, 2024) |
| Weeks tracked | 237 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LABETALOL HCL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0850 per EA (NDC 72888012001), effective Aug 19, 2026.
How has the price of LABETALOL HCL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 100 MG TABLET has declined 31.6%. It has been tracked across 237 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG TABLET?
Since Feb 9, 2022, the NADAC for LABETALOL HCL 100 MG TABLET has ranged from a low of $0.0789 (Mar 18, 2026) to a high of $0.1287 (Apr 13, 2022), with a median of $0.1052 per EA.
Are there cheaper alternatives to LABETALOL HCL 100 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LABETALOL HCL 100 MG TABLET, is $0.0807 per EA — about 5% below LABETALOL HCL 100 MG TABLET.
Who manufactures LABETALOL HCL 100 MG TABLET?
LABETALOL HCL 100 MG TABLET (NDC 72888012001) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.